A Study of CP-4126 in Patients With Advanced Pancreatic Cancer

Clinical trial NCT00913198 · COMPLETED

Trial details

NCT number: NCT00913198
Sponsor: Clavis Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Adenocarcinoma of Pancreas

Start date: 2009-04-01
Primary completion: 2011-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.